Global Morpho Pharma - A true global player
Global Morpho Pharma - A high reliable partner
Global Morpho Pharma - A superior quality source

About us

Global Morpho Pharma SAS is a French company created early 2018 that aims at developing, manufacturing, distributing and selling radionuclides and radiopharmaceuticals under Good Manufacturing Practice (GMP) quality for the benefit of the patients and the expanding nuclear medicine industry. Global Morpho Pharma intends to become one of the major suppliers of pharmaceutical grade doses of therapeutic radiolabeled compounds for the pharmaceutical industry.


In the therapeutic field Global Morpho Pharma anticipates very soon a massive need for high quality pharmaceutical grade radionuclides from alternative sources such as :

Lutetium-177 is a radioactive atom emitting beta particles (in other words electrons) and has the potential to destroy cells over a distance up to one millimeter in average. 177Lu has a half-life of 6.7 days and the quality of the product provided by the company is only non-carrier added (nca), meaning high specific activity and non-contamination with the long half-life impurity 177mLu.

Actinium-225 is a radioactive element emitting alpha particles (more than 7,000 times the size and weight of an electron) that has the potential to ionize strongly, and therefore destroy, over a distance of about the thickness of six cells. When combined with a vector targeting tumor cells, it will be able to kill efficiently but only over a short distance. 225Ac has a half-life of 9.91 days.

These sources need to be qualified and approved by the major authorities in the world and this process is under progress.


Global Morpho Pharma SAS pursues its development with a new CEO

Nantes, October 2nd, 2019 The board of Global Morpho Pharma SAS has the pleasure to announce that François Zimmermann will take over the position of Chief Executive Officer of the company. François will be located in Nantes together with his growing expert team. The company will move to a new office shortly. Pierre-Marie Lemer, chairman […]
EANM_2019_Global Morpho Pharma

EANM 2019 – Booth 101: Global Morpho Pharma is waiting for you in Barcelona

Global Morpho Pharma, a strategic supplier of therapeutic radionuclides, invites you to visit its booth at the annual EANM gathering in Barcelona, Oct. 12-16. In presence of the group’s partners, SCK-CEN & Spectron RX, and its team of experts, the company will reveal its strategy to develop a global distribution network for medical radionuclides for […]

SNMMI 2019 – Booth 565: Global Morpho Pharma and Spectron RX team up in Anaheim

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), a leading global force in the nuclear medicine community, will be hosting its 2019 edition of its annual congress in Anaheim, California from 22nd-25th June. A perfect opportunity for Global Morpho Pharma and its trusted Spectron RX to join forces under the same aegis. In fact, […]

SCK•CEN joins Global Morpho Pharma’s network and announces collaboration with IRE ELiT

Mol (Belgium), Nantes (France) and Fleurus (Belgium), 8 October 2018 The Belgian Nuclear Research Center (SCK•CEN) and Global Morpho Pharma today announced that they have signed a memorandum of understanding relative to the production and distribution of Good Manufacturing Practice grade therapeutics medical radionuclides. Under the terms of the agreement, SCK•CEN will join Global Morpho […]

Founders team

The core founding members of Global Morpho Pharma SAS include Dmitriy and Alexander Lintchevsky from the Russian company Komfins Service LLC, Pierre Marie Lemer, Valerie Chevreul and Xavier Gandillot from the French company Lemer Pax and Richard Zimmermann, from the French company Chrysalium Consulting.

Contact us

CAPTCHA failed. Please try again!

To find out more about how to know and exercise your rights, like the withdrawal of your consent to use submitted datas, please check out our privacy policy.

LEMER PAX / La chapelle-sur -Erdre, France


SPECTRON / South bend, Indianapolis IN, USA

Moscow, Russia

SCK.CEN / Mol, Belgium

Message Sent!
Thank you for your interest.
We are doing our best to get back to you shortly,
The Global Morpho Pharma team.
Sorry network issue,
please try again
or send us an email:
Thank you